Teleflex (NYSE:TFX) will be announcing its earnings results before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of $2.41 per share for the quarter.
Teleflex (TFX) opened at $260.96 on Thursday. The company has a current ratio of 4.72, a quick ratio of 3.70 and a debt-to-equity ratio of 0.88. Teleflex has a 12-month low of $175.68 and a 12-month high of $288.78. The stock has a market capitalization of $11,496.57, a price-to-earnings ratio of 46.52, a PEG ratio of 1.88 and a beta of 1.15.
In other Teleflex news, CEO Benson Smith sold 2,000 shares of the company’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $258.10, for a total value of $516,200.00. Following the sale, the chief executive officer now directly owns 76,634 shares of the company’s stock, valued at $19,779,235.40. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director George Babich, Jr. sold 2,500 shares of the company’s stock in a transaction on Monday, January 29th. The shares were sold at an average price of $283.11, for a total transaction of $707,775.00. Following the completion of the sale, the director now directly owns 9,581 shares in the company, valued at $2,712,476.91. The disclosure for this sale can be found here. Over the last three months, insiders sold 10,100 shares of company stock worth $2,671,994. 2.39% of the stock is owned by insiders.
ILLEGAL ACTIVITY WARNING: “Teleflex (TFX) Scheduled to Post Quarterly Earnings on Thursday” was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2018/02/15/teleflex-tfx-scheduled-to-post-quarterly-earnings-on-thursday.html.
Teleflex Company Profile
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.